跳至主要内容
临床试验/NCT00227708
NCT00227708已完成2 期

Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy Regimen With Bi-Weekly Docetaxel in the Treatment of Metastatic or Locally Advanced Non-Small Cell Lung Cancer in Patients Over the Age of 70

UNICANCER18 个研究点 分布在 3 个国家目标入组 58 人开始时间: 2005年6月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
UNICANCER
入组人数
58
试验地点
18
主要终点
Quality of life

研究概览

简要总结

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Chemotherapy drugs may have different effects in older patients.

PURPOSE: This phase II trial is studying how well docetaxel works in treating older patients with locally advanced or metastatic non-small cell lung cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the quality of life of older patients with locally advanced or metastatic non-small cell lung cancer treated with docetaxel.

Secondary

  • Determine the response rate in patients treated with this drug.
  • Determine the overall survival and progression-free survival of patients treated with this drug.
  • Determine the mood status and autonomy of activity of patients treated with this drug.
  • Determine the toxicity of this drug in these patients.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
70 Years 至 120 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Quality of life

次要结局

  • Response rate
  • Overall survival
  • Toxicity
  • Progression-free survival
  • Mood status and autonomy of activity

研究者

发起方
UNICANCER
申办方类型
Other

研究点 (18)

Loading locations...

相似试验